Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Unsupervised Machine Learning Model Using Multi-Parametric Radiomics for Prognostic Stratification of Bifocal Hepatocellular Carcinoma.

Journal of hepatocellular carcinoma·2026
Same author

Exploring the MRI and Clinical Features of P53-Mutated Hepatocellular Carcinoma.

Journal of hepatocellular carcinoma·2024
Same author

Estimating Microvascular Invasion in Patients with Resectable Multinodular Hepatocellular Carcinoma by Using Preoperative Contrast-Enhanced MRI: Establishment and Validation of a Risk Score.

Journal of hepatocellular carcinoma·2023
Same author

Crossover phenomena of percolation transition in evolution networks with hybrid attachment.

Chaos (Woodbury, N.Y.)·2016
Same author

Relation Between C-X-C Motif Chemokine Receptor 4 Levels and the Presence and Extent of Angiographic Coronary Collaterals in Patients With Chronic Total Coronary Occlusion.

The American journal of cardiology·2016
Same author

Quantify patient-specific coronary material property and its impact on stress/strain calculations using in vivo IVUS data and 3D FSI models: a pilot study.

Biomechanics and modeling in mechanobiology·2016
Same journal

Machine-Learning Based Prognostic Model for Predicting Early Recurrence in HCC Patients After Hepatectomies: An Explainable AI Approach.

Journal of hepatocellular carcinoma·2026
Same journal

Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted Immunotherapy.

Journal of hepatocellular carcinoma·2026
Same journal

Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma.

Journal of hepatocellular carcinoma·2026
Same journal

Current Status and Emerging Trends in Global Research on Liposome Therapy for Hepatocellular Carcinoma: A Bibliometric Analysis.

Journal of hepatocellular carcinoma·2026
Same journal

Integrating Combination Therapy and Smart Embolic Materials to Overcome the Therapeutic Ceiling of Transarterial Chemoembolization in Hepatocellular Carcinoma.

Journal of hepatocellular carcinoma·2026
Same journal

Putative Imprinting Control Regions with Aberrant Blood-Based DNA Methylation are Associated with Hepatocellular Carcinoma Risk.

Journal of hepatocellular carcinoma·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Multiparametric MRI-Based Machine Learning Radiomics Prognostic Models for Multifocal Hepatocellular Carcinoma Beyond

Xinyue Liang1,2,3, Fei Wu1,2,3, Xinde Zheng1,2,3

  • 1Shanghai Institute of Medical Imaging, Shanghai, People's Republic of China.

Journal of Hepatocellular Carcinoma
|September 3, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning radiomics models improve risk stratification for multifocal hepatocellular carcinoma (MHCC) beyond Milan criteria. These models enhance prediction of overall survival and recurrence-free survival for better patient outcomes.

Keywords:
MRIhepatocellular carcinomaradiomicsunsupervised learning

More Related Videos

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

2.4K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.4K

Related Experiment Videos

Last Updated: Sep 9, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

2.4K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.4K

Area of Science:

  • Hepatobiliary Malignancies
  • Medical Imaging and Radiomics
  • Machine Learning in Oncology

Background:

  • Multifocal hepatocellular carcinoma (MHCC) beyond Milan criteria presents a challenge for accurate preoperative risk stratification.
  • Existing models may not fully capture the prognostic complexity of advanced MHCC.
  • Novel approaches are needed to improve survival prediction in these patients.

Purpose of the Study:

  • To develop and validate machine learning radiomics models for preoperative risk stratification of MHCC.
  • To identify distinct radiomics-based patient subtypes for MHCC.
  • To assess the added value of radiomics in predicting overall survival (OS) and recurrence-free survival (RFS) beyond conventional criteria.

Main Methods:

  • Retrospective analysis of 156 MHCC patients beyond Milan criteria using multiparametric MRI (mpMRI).
  • Extraction of radiomic features from tumor and peritumor regions.
  • Application of spectral clustering for subtype identification and extreme gradient boosting (XGBoost)-LASSO Cox regression for risk score generation.

Main Results:

  • Two distinct radiomics-based patient subtypes were identified, with one subtype showing significantly worse OS and RFS.
  • Combined models incorporating radiomics predictors demonstrated improved OS prediction (C-index: 0.712 training, 0.710 validation) and RFS prediction (C-index: 0.735 training, 0.698 validation).
  • The models achieved good predictive performance for 5-year OS (AUC: 0.77 training, 0.75 validation) and RFS (AUC: 0.81 training, 0.76 validation).

Conclusions:

  • Machine learning radiomics models integrating mpMRI-derived features effectively predict outcomes in MHCC patients beyond Milan criteria.
  • These models offer improved preoperative risk stratification compared to conventional methods.
  • The findings support the use of radiomics for personalized treatment planning in advanced MHCC.